Form 4 for KVYO Klaviyo, Inc.
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001835830-24-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-18 | 2024-09-16 | KVYO | Chaves Allen | CTO | C - Cnv Deriv | $0.00 | +130.0K | 130.0K | New | $0 |
| DM | 2024-09-18 | 2024-09-16 | KVYO | Chaves Allen | CTO | S - Sale | $31.85 | -130.0K | 28.9K | -82% | -$4.14M |
| DM | 2024-09-18 | 2024-09-16+ | KVYO | Chaves Allen | CTO | M - OptEx | $0.00 | 0 | 356.3K | New | $0 |
| D | 2024-09-18 | 2024-09-16 | KVYO | Chaves Allen | CTO | C - Cnv Deriv | $0.00 | -130.0K | 226.3K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2024-09-16 | C | A | 130,000 | $0.00 | 130,000 | D | — | — | |
| 2 | Common | Series A Common Stock | 2024-09-16 | S | D | 28,934 | $31.21 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.65 to $31.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Series A Common Stock | 2024-09-16 | S | D | 101,066 | $32.03 | 28,934 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.50 to $32.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Series B Common Stock | 2024-09-17 | M | A | 32,733 | $0.00 | 259,047 | D | — · — to — | 32,733 Series A Common Stock | (F6) Consists of (i) 178,203 shares of Series B Common Stock and (ii) 80,844 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. (F5) Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-09-16 | M | D | 130,000 | $0.00 | 1,028,693 | D | $3.06 · — to 2030-04-15 | 130,000 Series B Common Stock | (F4) The shares underlying this option are fully vested and exercisable by the Reporting Person as of the date hereof. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-09-17 | M | D | 32,733 | $0.00 | 995,960 | D | $3.06 · — to 2030-04-15 | 32,733 Series B Common Stock | (F4) The shares underlying this option are fully vested and exercisable by the Reporting Person as of the date hereof. |
| 7 | Derivative | Series B Common Stock | 2024-09-16 | C | D | 130,000 | $0.00 | 226,314 | D | — · — to — | 130,000 Series A Common Stock | (F5) Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 8 | Derivative | Series B Common Stock | 2024-09-16 | M | A | 130,000 | $0.00 | 356,314 | D | — · — to — | 130,000 Series A Common Stock | (F5) Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |